What is the recommended treatment for a patient with chronic dermatitis?

Treatment of Chronic Dermatitis

For chronic dermatitis, begin with complete allergen/irritant avoidance combined with aggressive emollient therapy and mid-to-high potency topical corticosteroids, escalating to topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) for steroid-resistant or facial involvement, and reserve phototherapy or systemic immunosuppressants for severe refractory cases. 1, 2

First-Line Management: The Foundation

Immediate allergen/irritant identification and avoidance is the cornerstone of treatment—without this, all other therapies will fail. 1, 2 Replace all soaps and detergents with emollients immediately, as these are universal irritants that perpetuate inflammation even if they are not the primary cause. 1, 2

Emollient Therapy (Essential for All Patients)

• Apply moisturizers liberally and frequently—use two fingertip units to hands after each washing if hands are affected. 2, 3
• Use the "soak and smear" technique: soak affected areas in plain lukewarm water for 10-20 minutes, then immediately apply moisturizer to damp skin nightly for up to 2 weeks. 4, 2, 3
• Choose fragrance-free emollients packaged in tubes rather than jars to prevent contamination. 2
• For very dry skin, use ointment-based formulations; for less severe dryness, creams are acceptable. 4

Topical Corticosteroids (Primary Anti-Inflammatory Treatment)

• Start with mid-to-high potency topical corticosteroids (triamcinolone 0.1% or betamethasone valerate 0.1%) applied 2-3 times daily to affected areas. 1, 2, 3
• For severe or refractory cases, escalate to very high potency corticosteroids (clobetasol propionate 0.05%) twice daily for up to 2 weeks—this achieves clear or almost clear skin in 67.2% of severe cases compared to 22.3% with vehicle. 5, 3
• Critical safety parameters for topical corticosteroids: 6
  • Require regular clinical review with no unsupervised repeat prescriptions
  • Limit moderately potent preparations to no more than 100g per month
  • Mandate periods each year when alternative treatments are employed
  • Reserve very potent or potent preparations for dermatological supervision

Common pitfall: Avoid prolonged use of potent corticosteroids on facial skin—this causes skin thinning, telangiectasia, perioral dermatitis, and red face syndrome due to increased percutaneous absorption. 2

Second-Line Treatment: Topical Calcineurin Inhibitors

When topical corticosteroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage, switch to topical calcineurin inhibitors. 1, 2, 5

• Tacrolimus 0.1% ointment applied twice daily is effective for contact dermatitis and improves induration and scaling while avoiding risks of long-term corticosteroid use. 1, 5
• Pimecrolimus 1% cream is FDA-approved as second-line therapy for short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in patients 2 years and older who have failed other topical treatments. 7
• These agents are particularly valuable for sensitive sites such as the face, neck, and flexural areas. 4, 2

Important FDA warning: Pimecrolimus should not be used continuously for long periods due to theoretical cancer risk (skin or lymphoma), though a causal link has not been established. 7 Use only on areas with active dermatitis, not as prophylaxis. 7

Protective Measures and Substitution Strategies

Hand Protection (Critical for Hand Dermatitis)

• Use rubber or PVC gloves with cotton liners for general household tasks. 1, 2
• Remove gloves regularly to prevent sweat accumulation, which aggravates dermatitis. 2
• For latex allergy, use accelerator-free neoprene or nitrile gloves. 2, 3
• Select gloves based on specific chemical exposures and check Material Safety Data Sheets for permeation times—no glove is completely impermeable. 2

Critical pitfall: Do not over-rely on barrier creams alone—they have questionable clinical value and may create false security, reducing implementation of appropriate preventive measures. 1, 2

Material Substitution

• Use thiuram-free gloves for rubber chemical allergy. 1, 2
• Switch to isothiazolinone-free creams and cleansers for preservative allergy. 1, 2
• Change biocides in industrial coolant oils for occupational exposures. 2

Diagnostic Workup for Persistent Cases

Obtain patch testing with an extended baseline series of allergens for any persistent or chronic dermatitis lasting beyond 2 weeks despite appropriate treatment. 1, 2, 5, 3 Pattern and morphology alone are unreliable in distinguishing between irritant, allergic, or endogenous dermatitis, particularly on hands and face. 1, 2, 5

Testing considerations: 2

• Do not apply potent topical steroids to the back within 2 days of patch testing—this causes false negatives
• Avoid oral corticosteroids or immunosuppressants during testing; if unavoidable, keep prednisolone ≤10mg daily
• Consider testing for corticosteroid allergy if dermatitis worsens with treatment

Third-Line Treatment: Phototherapy

PUVA (psoralen plus UVA) therapy is an established second-line treatment for chronic dermatitis resistant to topical steroids, supported by prospective clinical trials. 1, 8, 2, 5 This is particularly effective for chronic hand eczema and widespread disease. 1, 8

Alternative phototherapy options include narrow-band UVB (NB-UVB), broad-band UVB (BB-UVB), and UVA, though head-to-head comparative data are limited. 8

Fourth-Line Treatment: Systemic Immunosuppressants

For steroid-resistant chronic dermatitis, consider systemic agents under dermatology supervision: 1, 8, 2

• Methotrexate or mycophenolate mofetil for general immunosuppression
• Azathioprine (particularly effective for chronic actinic dermatitis) 1
• Ciclosporin (demonstrated useful in chronic hand dermatitis) 1, 8
• Alitretinoin specifically for severe chronic hand eczema (strong recommendation) 1, 2
• Dupilumab for severe chronic atopic dermatitis in adults and children 9, 10

Patient Education and Prognosis

Implement comprehensive educational programs for occupational contact dermatitis—these demonstrate improvements in established hand dermatitis and prevention of new cases. 1, 2 However, compliance with skin-protection programs is often poor and requires ongoing reinforcement. 1

Realistic prognostic counseling is essential: 1, 2, 5, 3

• Only 25% of patients with occupational contact dermatitis achieve complete healing over 10 years
• 50% will have intermittent symptoms and 25% will have permanent symptoms despite treatment
• Changing occupation does not improve prognosis in 40% of cases
• Early identification and complete avoidance of allergens offers the best chance for resolution

Critical Pitfalls to Avoid

• Never recommend exclusion diets—no good-quality studies support their use in contact dermatitis management. 1, 2
• Avoid washing with dish detergent, very hot or very cold water, or disinfectant wipes. 2, 3
• Do not apply products containing topical antibiotics without clear indication—these are common sensitizers (especially neomycin and bacitracin). 3
• Avoid prolonged occlusion without underlying moisturizer application. 2, 3
• Do not use sun lamps, tanning beds, or ultraviolet light therapy while using topical calcineurin inhibitors. 7

Special Considerations for Occupational Dermatitis

Arrange workplace visits to identify hidden allergens, assess procedures causing accidental exposure, and review Material Safety Data Sheets. 1, 2 This is essential for effective treatment and prevention, as workplace assessment may reveal exposures not apparent from history alone. 1, 2